Formation Bio继续在华大举收购，斥资5亿美元达成自身免疫性疾病生物技术协议。
Formation Bio’s China shopping spree continues with $500M biobucks autoimmune pact
生命科学资讯
生物技术与制药领域的最新动态
生物制药行业2026年展望：乐观与压力并存
The biopharma industry outlook on 2026: Optimism and tension
武田制药"预期"其畅销药Entyvio将进入医保谈判。
Takeda 'anticipated' Medicare negotiations for top seller Entyvio
人类重返月球之际，科学家直面深空辐射风险
As humans return to the Moon, scientists confront the dangers of deep-space radiation
武田制药候任CEO表示，不赞成特朗普的最惠国待遇协议。
Takeda is ‘not in favor’ of Trump’s MFN deals, CEO-designate says
白宫推迟原定特朗普处方药计划发布会
White House postpones planned TrumpRx launch event
龙沙集团持续利用生物制药优化趋势（场外交易代码：LZAGY）——Seeking Alpha
Lonza Group Continues To Leverage Biopharma’s Optimization Push (OTCMKTS:LZAGY) - Seeking Alpha
滑倒的科学…怪分子！
The Science of Slipping… Blame the Molecules!
赛诺菲预期疫苗销售增长放缓，面临“挑战性环境”
Sanofi expects vaccine sales growth to dip amid ‘challenging environment’
赛诺菲疫苗业务受挫，誓言坚守承诺不动摇。
Sanofi vows to stay committed to vaccines as portfolio takes a hit
药房初创企业的命运多舛
The disrupted fate of pharmacy startups
罗氏2025年利润因美元走软而受挫——医药科技
Roche’s 2025 profit blunted by weakened US dollar - Pharmaceutical Technology
Ro60与La自身抗原的RNA伴侣机制解析
Mechanistic insights into RNA chaperoning by Ro60 and La autoantigens
一种用于构建体内吸收不良生物传感器的拟杆菌合成生物学工具包
A Bacteroides synthetic biology toolkit to build an in vivo malabsorption biosensor
CRISPR筛选揭示iPSC衍生神经元中tau蛋白稳态调控机制
CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis
RFC在PCNA介导的进程性DNA合成中的非催化作用
A non-catalytic role for RFC in PCNA-mediated processive DNA synthesis
罗氏诊断业务在2025年微增2%，中国市场逆风冲击亚太区销售。
Roche diagnostics business nudges up 2% in '25 as China headwinds buffet Asia-Pacific sales
比利时生物技术公司Agomab拟纳斯达克上市融资2.12亿美元，支持免疫学试验。
Belgium biotech Agomab outlines up to $212M Nasdaq debut to fund immunology trials
赛诺菲放弃开发下一代mRNA季节性流感疫苗。
Sanofi abandons attempt to develop next-gen mRNA seasonal flu vaccine
阿斯利康计划投资150亿美元深化在华合作。
AstraZeneca strengthens China ties with planned $15B investment